OBJECTIVE: To explore the experiences of family physicians and respiratory therapists in treating advanced chronic obstructive pulmonary disease (COPD) and their attitudes to the use of opioids for dyspnea in this context. DESIGN: Qualitative methodology using one-on-one semistructured interviews. SETTING: Southern New Brunswick (St Stephen to Sussex). PARTICIPANTS: Ten family physicians and 8 respiratory therapists who worked in primary care settings. METHODS: Participant interviews were audiorecorded, transcribed verbatim, coded conceptually, and thematically analyzed using interpretive description. MAIN FINDINGS: Participants reported that patients with advanced COPD often suffered from inadequate control of their dyspnea in advanced stages and that they saw the potential value of opioids in this context; however, family physicians described discomfort prescribing opioids. Barriers included insufficient knowledge, lack of education and guidelines, and fear of censure. Those with palliative care experience tended to be more comfortable with opioid prescribing. CONCLUSION: Findings suggest an important need to address barriers related to more effective treatment of refractory dyspnea in advanced COPD. Further, findings indicate these efforts should focus on effective palliation and innovative educational initiatives, as well as the development, promotion, and uptake of evidence-based practice guidelines related to prescribing opioids for these patients.
OBJECTIVE: To explore the experiences of family physicians and respiratory therapists in treating advanced chronic obstructive pulmonary disease (COPD) and their attitudes to the use of opioids for dyspnea in this context. DESIGN: Qualitative methodology using one-on-one semistructured interviews. SETTING: Southern New Brunswick (St Stephen to Sussex). PARTICIPANTS: Ten family physicians and 8 respiratory therapists who worked in primary care settings. METHODS:Participant interviews were audiorecorded, transcribed verbatim, coded conceptually, and thematically analyzed using interpretive description. MAIN FINDINGS:Participants reported that patients with advanced COPD often suffered from inadequate control of their dyspnea in advanced stages and that they saw the potential value of opioids in this context; however, family physicians described discomfort prescribing opioids. Barriers included insufficient knowledge, lack of education and guidelines, and fear of censure. Those with palliative care experience tended to be more comfortable with opioid prescribing. CONCLUSION: Findings suggest an important need to address barriers related to more effective treatment of refractory dyspnea in advanced COPD. Further, findings indicate these efforts should focus on effective palliation and innovative educational initiatives, as well as the development, promotion, and uptake of evidence-based practice guidelines related to prescribing opioids for these patients.
Authors: Darcy D Marciniuk; Donna Goodridge; Paul Hernandez; Graeme Rocker; Meyer Balter; Pat Bailey; Gord Ford; Jean Bourbeau; Denis E O'Donnell; Francois Maltais; Richard A Mularski; Andrew J Cave; Irvin Mayers; Vicki Kennedy; Thomas K Oliver; Candice Brown Journal: Can Respir J Date: 2011 Mar-Apr Impact factor: 2.409
Authors: Paul N Lanken; Peter B Terry; Horace M Delisser; Bonnie F Fahy; John Hansen-Flaschen; John E Heffner; Mitchell Levy; Richard A Mularski; Molly L Osborne; Thomas J Prendergast; Graeme Rocker; William J Sibbald; Benjamin Wilfond; James R Yankaskas Journal: Am J Respir Crit Care Med Date: 2008-04-15 Impact factor: 21.405
Authors: Donald A Mahler; Paul A Selecky; Christopher G Harrod; Joshua O Benditt; Virginia Carrieri-Kohlman; J Randall Curtis; Harold L Manning; Richard A Mularski; Basil Varkey; Margaret Campbell; Edward R Carter; Jun Ratunil Chiong; E Wesley Ely; John Hansen-Flaschen; Denis E O'Donnell; Alexander Waller Journal: Chest Date: 2010-03 Impact factor: 9.410
Authors: Marjolein Lugtenberg; Jako S Burgers; Casper F Besters; Dolly Han; Gert P Westert Journal: BMC Fam Pract Date: 2011-09-22 Impact factor: 2.497
Authors: Nicholas T Vozoris; Xuesong Wang; Hadas D Fischer; Andrea S Gershon; Chaim M Bell; Sudeep S Gill; Denis E O'Donnell; Peter C Austin; Anne L Stephenson; Paula A Rochon Journal: Br J Clin Pharmacol Date: 2015-10-02 Impact factor: 4.335
Authors: Cornelia A Verberkt; Marieke H J van den Beuken-van Everdingen; Jos M G A Schols; Niels Hameleers; Emiel F M Wouters; Daisy J A Janssen Journal: JAMA Intern Med Date: 2020-10-01 Impact factor: 21.873
Authors: Graeme M Rocker; A Catherine Simpson; Robert Horton; Tasnim Sinuff; Jillian Demmons; Paul Hernandez; Darcy Marciniuk Journal: CMAJ Open Date: 2013-01-24
Authors: Anand S Iyer; James Nicholas Dionne-Odom; Dina M Khateeb; Lanier O'Hare; Rodney O Tucker; Cynthia J Brown; Mark T Dransfield; Marie A Bakitas Journal: J Palliat Med Date: 2019-10-29 Impact factor: 2.947
Authors: Marjolein Lugtenberg; Jan-Willem Weenink; Trudy van der Weijden; Gert P Westert; Rudolf B Kool Journal: BMC Med Inform Decis Mak Date: 2015-10-12 Impact factor: 2.796